Zinc in PDB 1n9a: Farnesyltransferase Complex with Tetrahydropyridine Inhibitors

The structure of Farnesyltransferase Complex with Tetrahydropyridine Inhibitors, PDB code: 1n9a was solved by S.L.Gwaltney Ii, S.J.O'conner, L.T.Nelson, G.M.Sullivan, H.Imade, W.Wang, L.Hasvold, Q.Li, J.Cohen, W.Z.Gu, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	40.12 / 3.20
Space group	P 61
Cell size a, b, c (Å), α, β, γ (°)	170.503, 170.503, 69.272, 90.00, 90.00, 120.00
R / Rfree (%)	32.9 / 37.5

The binding sites of Zinc atom in the Farnesyltransferase Complex with Tetrahydropyridine Inhibitors (pdb code 1n9a). This binding sites where shown within 5.0 Angstroms radius around Zinc atom.
In total only one binding site of Zinc was determined in the Farnesyltransferase Complex with Tetrahydropyridine Inhibitors, PDB code: 1n9a:

Zinc binding site 1 out of 1 in the Farnesyltransferase Complex with Tetrahydropyridine Inhibitors


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 1 of Farnesyltransferase Complex with Tetrahydropyridine Inhibitors within 5.0Å range: probe atom residue distance (Å) B Occ B:Zn500 b:30.0 occ:1.00 OD2 B:ASP297 1.8 55.7 1.0 SG B:CYS299 2.2 36.3 1.0 NE2 B:HIS362 2.3 32.3 1.0 CG B:ASP297 2.4 55.7 1.0 OD1 B:ASP297 2.4 55.7 1.0 CD2 B:HIS362 3.2 32.3 1.0 CB B:CYS299 3.3 36.3 1.0 CE1 B:HIS362 3.4 32.3 1.0 N2 B:FTI1 3.5 30.0 1.0 CB B:ASP297 3.8 55.7 1.0 CE2 B:TYR361 3.9 15.1 1.0 N B:CYS299 3.9 53.5 1.0 CA B:CYS299 4.3 53.5 1.0 CG B:HIS362 4.3 32.3 1.0 OD2 B:ASP352 4.4 33.3 1.0 ND1 B:HIS362 4.4 32.3 1.0 C19 B:FTI1 4.4 30.0 1.0 C17 B:FTI1 4.5 30.0 1.0 CG B:ASP352 4.5 33.3 1.0 OH B:TYR361 4.5 15.1 1.0 CB B:ASP352 4.7 33.3 1.0 CE1 B:TYR300 4.7 69.0 1.0 CZ B:TYR361 4.7 15.1 1.0 C B:ASP297 4.8 70.0 1.0 CD2 B:TYR361 4.8 15.1 1.0 CA B:ASP297 4.8 70.0 1.0 CD1 B:TYR300 4.9 69.0 1.0 CA B:ASP352 4.9 88.2 1.0 N B:GLY298 5.0 55.1 1.0

S.L.Gwaltney Ii, S.J.O'connor, L.T.Nelson, G.M.Sullivan, H.Imade, W.Wang, L.Hasvold, Q.Li, J.Cohen, W.Z.Gu, S.K.Tahir, J.Bauch, K.Marsh, S.C.Ng, D.J.Frost, H.Zhang, S.Muchmore, C.G.Jakob, V.Stoll, C.Hutchins, S.H.Rosenberg, H.L.Sham. Aryl Tetrahydropyridine Inhibitors of Farnesyltransferase: Bioavailable Analogues with Improved Cellular Potency. Bioorg.Med.Chem.Lett. V. 13 1363 2003.
ISSN: ISSN 0960-894X
PubMed: 12657283
DOI: 10.1016/S0960-894X(03)00094-5